DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Diener HC. RPR100893 Study Group.
RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks
Cephalalgia 2003; 23(3): 183-185
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.